Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware District of Columbia Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming

About Michael Silber

This author has not yet filled in any details.
So far Michael Silber has created 2747 blog entries.

Minnesota

The Minnesota Department of Health (MDH) will host a public, virtual meeting on Wednesday, December 29, 2021, at 2 p.m. CST to demonstrate the functionality of the registration system and provide an update on the technical build for the Prescription Drug Price Transparency Act (the "Act") (Minnesota Statutes 62J.84; amended by Minnesota Laws, 2021, Regular Session, Chapter 30 – HF 2128 – Article 3, Sec. 5 – 9). To join, use the  Webex Meeting Link, Meeting Number (access code): 2494 346 4226, Meeting Password: tXaTGFdT722. MDH will post–meeting materials on the Prescription Drug Price Transparency Meetings page. Additional information is available online at www.health.state.mn.us/data/rxtransparency, where interested individuals and stakeholders may also subscribe to periodic updates. 

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2021-12-17T11:54:01-05:00December 17, 2021|Minnesota|

Missouri

The RX Cares for Missouri Program, administered by the Missouri Board of Pharmacy, is seeking grant funding proposals for the purpose of developing or providing programs or education to promote medication safety or prevent prescription drug abuse, misuse, and diversion. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2021-12-17T11:53:05-05:00December 17, 2021|Missouri|

Nebraska

The Department of Health and Human Services (DHHS) issued Provider Bulletin 21- 25 announcing December 2021 COVID-19 Vaccine Updates featuring updates on booster doses. 

Also in Nebraska, the Department of Health and Human Services announced the next COVID-19 Medicaid Provider call will take place on January 5, 2022, at noon (Central). 

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2021-12-17T11:52:35-05:00December 17, 2021|Nebraska|

New Mexico

The New Mexico Board of Pharmacy rules now allow Certified Immunization Pharmacy Technicians to vaccinate ALL vaccines to anyone prescribed by their Supervising Pharmacist, effective November 30, 2021. 

Also in New Mexico, Gov. Michelle Lujan Grisham (D) extended the Public Health Order requiring masks indoors in all public settings through January 7th, 2022.  

For more information, contact NACDS' Mary Staples at 817-308-2103. 

North Carolina: The North Carolina Board of Pharmacy published proposed administrative rules concerning pharmacy interns. These rules can be found beginning on Page 1049 (PDF Page 57) of the North Carolina Register. 

The Board will hold a public hearing on these rules on February 8, 2022. The public hearing will be held remotely. The public can participate on Teams at https://tinyurl.com/jsuk4bjk or call 336-604-5350, conference ID 903 191 899#. The Board will accept written comments until February 14, 2022, and should be submitted to Jay Campbell, 6015 Farrington Road, Suite 201, Chapel Hill, NC 27517; fax (919) 246-1056; email ncboprulemaking@ncbop.org. 

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2021-12-17T11:51:43-05:00December 17, 2021|New Mexico|

North Carolina

The North Carolina Board of Pharmacy published proposed administrative rules concerning pharmacy interns. These rules can be found beginning on Page 1049 (PDF Page 57) of the North Carolina Register. 

The Board will hold a public hearing on these rules on February 8, 2022. The public hearing will be held remotely. The public can participate on Teams at https://tinyurl.com/jsuk4bjk or call 336-604-5350, conference ID 903 191 899#. The Board will accept written comments until February 14, 2022, and should be submitted to Jay Campbell, 6015 Farrington Road, Suite 201, Chapel Hill, NC 27517; fax (919) 246-1056; email ncboprulemaking@ncbop.org. 

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2021-12-17T11:50:23-05:00December 17, 2021|North Carolina|

Oregon

The Board of Pharmacy adopted the following permanent rules effective last Friday, December 10. 

Also in Oregon, the Board of Pharmacy adopted the following temporary rules effective last Friday, December 10. 

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2021-12-17T11:48:28-05:00December 17, 2021|Oregon|

Rhode Island

On Wednesday, December 15th ,Governor McKee held a news conference to announce that he will be instituting several COVID mitigation measures, one being a modified mask mandate, in Rhode Island. If the space can hold 250 or more, masks will be required, under 250, masks or proof of vaccine will be required. See the official Executive Order. These temporary measures will take effect on Monday, December 20, 2021.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2021-12-17T11:46:36-05:00December 17, 2021|Rhode Island|

Utah

The Division of Occupational and Professional Licensing published a proposed rule to implement SB 177 and HB 178 enacted earlier this year, to amend the rule in accordance with Executive Order 2021-12 and to make changes consistent with Office of Administrative Rule's current Rule Writing Manual. The deadline for written comments is January 14, 2022. Below is an outline of the various proposed amendments: 

  • Section R156-17b-102: to add definitions for "consulting pharmacist," "designated representative," and "responsible individual," and clarify that compounding as defined in Section 58-17b-102(18) does not include adding flavoring agents to conventionally manufactured and commercially available liquid medication if the flavoring agents are therapeutically inert and do not exceed five percent of a preparation's total volume. 
  • Sections R156-17b-601 and R156-17b-612: permits a pharmacy technician or pharmacy intern to transfer a legend prescription and permit dispensing of emergency prescriptions. 
  • Section R156-17b-603: to require a consulting pharmacist, PIG, RDPIC, or DMPIC to complete a self-audit after certain changes and prior to the end of a renewal cycle. 
  • Section R156-17b-614a: to clarity that the pharmacy department shall be equipped with a lock where drugs are stored. 
  • Section R156-17b-621a: to delete the continuing education requirement for pharmacists engaging in the administration of long-acting injectable drugs. 

 Also, the addition of Section R156-17b-627 defines operating standards for a pharmacist prescribing prescription drugs or devices.  

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2021-12-17T10:41:08-05:00December 17, 2021|Utah|
Go to Top